{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":1,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":1,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"cb40d4be59b0","filters":{"venue":"Journal of Dermatologic Research And Therapy"}},"results":[{"id":"W2773756552","doi":"10.14302/issn.2471-2175.jdrt-17-1760","title":"Blockade of Programmed Cell Death Protein-1 Pathway for the Treatment of Melanoma","year":2017,"lang":"en","type":"article","venue":"Journal of Dermatologic Research And Therapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Nivolumab; Pembrolizumab; Ipilimumab; Medicine; Melanoma; Dacarbazine; Oncology; Internal medicine; Blockade; Cancer; Adverse effect; Immune checkpoint; PD-L1; Immunotherapy; Cancer research","authors":[{"name":"Madhuri Bhandaru","is_ca":true},{"name":"Anand Rotte","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1412676086609013,"gpt":0.3993332796148271,"spread":0.2580656709539259,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002028177,0.0001845745,0.000217242,0.0003597512,0.0001297802,0.0002804358,0.0001518919,0.0002261246,0.001647438],"category_scores_gemma":[0.0001371554,0.000048117,0.0002987831,0.0001602833,0.0001575279,0.0002491688,0.0002075005,0.0009552895,0.0004310225],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002146406,"about_ca_system_score_gemma":0.0002514875,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001313819,"about_ca_topic_score_gemma":0.0004964761,"domain_scores_codex":[0.9999309,0.00001633915,0.000005548009,0.0000099714,0.00002584523,0.00001130203],"domain_scores_gemma":[0.9999648,0.000006860898,0.00000983988,0.000002577385,0.000007754342,0.000008062793],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0006522784,0.0004991141,0.0008866113,0.002208722,0.0001128451,0.000585468,0.00005961616,0.0004756969,0.08860365,0.004370347,0.01772542,0.8838202],"study_design_scores_gemma":[0.0009033596,0.005145995,0.01031831,0.001074202,0.0003650714,0.01123901,0.00009417254,0.002131024,0.1048369,0.006699604,0.857132,0.00006027709],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.04633035,0.9277865,0.005016264,0.004376668,0.001133637,0.0001078199,0.0001268871,0.0002104094,0.01491151],"genre_scores_gemma":[0.4025417,0.5765513,0.005365427,0.002049735,0.001034758,0.00009808027,0.0003168275,0.00002600612,0.0120162],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.001647438,"threshold_uncertainty_score":0.005511224,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}